{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:43:08Z","timestamp":1777527788404,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clbc.2016.06.016","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:34:53Z","timestamp":1467765293000},"page":"494-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Jocelyn","family":"S. Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Panighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-may","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2016.06.016_bib1","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrance: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2016.06.016_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2016.06.016_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.06.016_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.06.016_bib5","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.06.016_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domcheck","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2016.06.016_bib7","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","article-title":"Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis","volume":"20","author":"Grann","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.06.016_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2016.06.016_bib9","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Genetic\/familial high-risk assessment: breast and ovarian. Version 1.2010. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed: January 16, 2016."},{"key":"10.1016\/j.clbc.2016.06.016_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.06.016_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2016.06.016_bib12","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","article-title":"Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations","volume":"91","author":"Robson","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2016.06.016_bib13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","article-title":"Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients","volume":"22","author":"Schwartz","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.06.016_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","article-title":"Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy","volume":"98","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clbc.2016.06.016_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2407-8-101","article-title":"Coordinated prophylactic surgical management for women with hereditary breast\u2013ovarian cancer syndrome","volume":"8","author":"Batista","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2016.06.016_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/SAP.0b013e3181a2c6bd","article-title":"Safety and efficacy of perforator flap breast reconstruction with combined intraabdominal procedures","volume":"64","author":"William","year":"2010","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.clbc.2016.06.016_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3816\/CBC.2007.n.053","article-title":"Bilateral risk-reducing oophorectomy and bilateral risk-reducing mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Friebel","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2016.06.016_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor\u2013negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2016.06.016_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clbc.2016.06.016_bib20","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2016.06.016_bib21","unstructured":"Informed Medical Decisions Foundation. Affordable Care Act. Available at: http:\/\/www.informedmedicaldecisions.org\/shareddecisionmaking.aspx. Accessed: February 17, 2016."},{"key":"10.1016\/j.clbc.2016.06.016_bib22","unstructured":"National Institutes of Health; National Cancer Institute. Shared decision making to improve cancer screening choices. Available at: http:\/\/www.cancer.gov\/about-cancer\/screening\/research\/shared-decision-making. Accessed: February 17, 2016."}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820916301719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820916301719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:51Z","timestamp":1761513291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820916301719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1526820916301719"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2016.06.016","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2016.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}